Model 1 | Model 2 | Model 3 | Model 4 | |||||
---|---|---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
All patients | ||||||||
[50–90) | 5.76** | 1.77–18.75 | 7.92** | 2.23–27.19 | 7.21** | 2.01–25.75 | 6.37** | 1.76–23.04 |
[90–130) | 6.63** | 2.39–18.35 | 6.99** | 2.46–19.88 | 7.51** | 2.59–21.78 | 6.77** | 2.31–19.81 |
[130–170] | 3.11* | 1.12–8.64 | 3.15* | 1.11–8.96 | 3.15* | 1.09–9.08 | 3.40* | 1.17–9.92 |
[170–210) | 1 | 1 | 1 | 1 | ||||
AD patients | ||||||||
[50–90) | 8.55** | 1.94–37.60 | 9.08** | 2.10-39.19 | 10.27** | 2.48–42.53 | 5.43** | 1.41–20.87 |
[90–130) | 6.38** | 1.82–22.33 | 6.76** | 1.96–23.26 | 6.22** | 1.88–20.51 | 5.00** | 1.56–15.98 |
[130–170) | 3.72* | 1.06–13.02 | 3.26 | 0.95–11.17 | 3.23 | 0.97–10.79 | 2.51 | 0.77–8.13 |
[170–210) | 1 | 1 | 1 | 1 | ||||
LBD patients | ||||||||
[50–90) | 7.51 | 0.60-93.59 | 2.38 | 0.13–41.15 | 4.48 | 0.15-128.05 | 2.91 | 0.06-127.01 |
[90–130) | 18.57* | 2.05-167.58 | 9.64 | 0.93–99.32 | 18.51* | 1.18-290.13 | 25.63 | 0.97-676.92 |
[130–170) | 6.82 | 0.80-57.93 | 2.06 | 0.19–22.35 | 3.33 | 0.21–53.05 | 5.51 | 0.20-149.95 |
[170–210) | 1 | 1 | 1 | 1 |